Table 1.
AFP, alpha-fetoprotein; HBV, hepatitis B; HCV, hepatitis C; MELD, model for end-stage liver disease; TACE, transarterial chemoembolization.
AFP, alpha-fetoprotein; HBV, hepatitis B; HCV, hepatitis C; MELD, model for end-stage liver disease; TACE, transarterial chemoembolization.